BLUEJET₹575.00

Blue Jet Healthcare Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersDIVISLABAARTIPHARMCAPLIPOINTACUTAASCONCORDBIOEMCUREERISGRANULES
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
Last 12M
30/06/2026
Revenue from Operations——885.7
Other Income——75.6
Total Income——961.3
Expenses
+ Cost of Materials Consumed——459.1
+ Changes in Inventories——-69.1
+ Employee Benefit Expense——76.2
+ Finance Costs——6.2
+ Depreciation & Amortisation——25.0
+ Other Expenses——148.2
Total Expenses——645.7
EBITDA——271.2
EBIT——246.2
Profit
PBT before Exceptional Items——315.6
Pretax Income——315.6
+ Current Tax——78.0
+ Deferred Tax——2.7
Tax Expense——80.7
Net Income——234.9
+ Net Income — Continuing Ops——234.9
+ Other Comprehensive Income——-0.2
Total Comprehensive Income——234.7
Per Share
Basic EPS——13.55
Diluted EPS——13.55
Other Comprehensive Income — detail
+ Other Comprehensive Income——-0.2
+ Tax on Items NOT to be Reclassified——-0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations——13.55
Diluted EPS — Continuing Operations——13.55
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit——495.6
Gross Margin %——55.96
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)——315.6
Net Income Adj (tax-effected)——234.9
EPS Adj——13.55
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value——2.00
Paid Up Equity Capital——34.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 97%.